지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술대회자료
- 저자정보
- 저널정보
- 대한약학회 대한약학회 학술대회 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
- 발행연도
- 2003.1
- 수록면
- 2,502 - 2,502 (1page)
이용수
초록· 키워드
오류제보하기
There are contradicting reports on the nephrotoxicity of heptaplatin, a new platinum derivative. A retrospective study was performed to compare the toxicities of heptaplatin-containing regimens with the ones not. Seventy-seven patients with advanced gastric cancer who did not receive any chemotherapy within the last 3 months before the treatment were evaluated. Among them 38 patients received heptaplatin-containing regimens (heptaplatin/epirubicin/5-FU: 26, heptaplatin/5-FU: 12) and 39 patients received other regimens (cisplatin/epirubicin/5-FU:11, epirubicin/leucovorin/5-FU: 28). (omitted)
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
말기 암환자에 투여한 Heptaplatin의 신독성에 대한 후향적 평가
한국임상약학회지
2006 .01
-
Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
Cancer Research and Treatment
2009 .01
-
A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer
Cancer Research and Treatment
2005 .01
-
Heptaplatin의 신독성 : 진행성 위암에서 Cisplatin과의 무작위 비교연구
대한임상약리학회 학술대회
2001 .01
-
Pilot Study of Heptaplatin, UFT-E and Leucovorin in Advanced Gastric Carcinoma
Cancer Research and Treatment
2003 .01
-
신규항암제인 Heptaplatin의 인체 흑색종세포(SK-MEL-28)에 대한 세포생존률 및 유세포 분석
약학회지
2003 .01
-
Phase I and Pharmacokinetic Study of Intraoperative Intraperitoneal Heptaplatin in Patients with SurgicallyResected Advanced Gastric Cancer
Cancer Research and Treatment
2003 .01
-
Combination Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study
Cancer Research and Treatment
2004 .01
-
진행성 및 재발성 위암 환자에서 5-Fluorouracil, heptaplatin 및 UFT 복합항암화학요법의 효과
대한내과학회지
2004 .01
-
인체 흑색종 세포(SK-MEL-28 Cell Line)에서 Cisplatin, Heptaplatin, 그리고 Sulpla에 의한 Apoptosis의 유도
약학회지
2004 .01
-
진행성 위암 환자에서 Heptaplatin과 5-Fluorouracil 복합요법의 임상효과
한국임상약학회지
2004 .01
-
전이성 위암환자에서 2선 요법으로서의 leucovorin과 5-FU 혼합지속주입요법(LF지속요법)의 효과
대한내과학회지
2002 .01
-
Efficacy and Safety of Docetaxel or Epirubicin, Combined with Cisplatin and Fluorouracil, (DCF and ECF) Regimens as First Line Chemotherapy for Advanced Gastric Cancer: a Retrospective Analysis from Turkey
Asian Pacific journal of cancer prevention : APJCP
2014 .01
-
Comparison of Efficacy and Toxicity of First Line Chemotherapy with or without Epirubicin for Patients with Advanced Stage Soft Tissue Sarcoma
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Cancer Research and Treatment
2011 .01
-
Can Capecitabine be used Instead of Concurrent Bolus 5-FU in Postoperative Chemoradiotherapy for Gastric Adenocarcinoma?
Asian Pacific journal of cancer prevention : APJCP
2013 .01
-
Outcomes of Modified FOLFOX-6 as First Line Treatment in Patients with Advanced Gastric Cancer in a Single Institution; Retrospective Analysis
Cancer Research and Treatment
2010 .01
-
Salvage Treatment for Advanced Gastric Cancer Using FEP (5-FU, Etoposide, Cisplatin) Combination Chemotherapy
Cancer Research and Treatment
2002 .01
-
Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric Cancer
Cancer Research and Treatment
2004 .01
-
A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-FluorouracilRefractory Colorectal Cancer
Cancer Research and Treatment
2002 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0